Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127483441 | 12748344 | 1 | I | 201601 | 20160905 | 20160915 | 20160915 | EXP | BR-SA-2016SA168708 | AVENTIS | 61.00 | YR | A | F | Y | 0.00000 | 20160915 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127483441 | 12748344 | 1 | PS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | U | UNKNOWN | 21081 | 24 | IU | INJECTION | QD | |||||
| 127483441 | 12748344 | 2 | SS | APIDRA SOLOSTAR | INSULIN GLULISINE | 1 | Unknown | U | UNKNOWN | 21629 | |||||||||
| 127483441 | 12748344 | 3 | SS | TOUJEO | INSULIN GLARGINE | 1 | Unknown | UNKNOWN | 21081 | 24 | IU | QD | |||||||
| 127483441 | 12748344 | 4 | C | SOLOSTAR | DEVICE | 1 | 0 | QD | |||||||||||
| 127483441 | 12748344 | 5 | C | SOLOSTAR | DEVICE | 1 | 0 | ||||||||||||
| 127483441 | 12748344 | 6 | C | SOLOSTAR | DEVICE | 1 | 0 | QD | |||||||||||
| 127483441 | 12748344 | 7 | C | LEVOID | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 127483441 | 12748344 | 8 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 127483441 | 12748344 | 9 | C | INVOKANA | CANAGLIFLOZIN | 1 | 0 | ||||||||||||
| 127483441 | 12748344 | 10 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 127483441 | 12748344 | 11 | C | AAS | ASPIRIN | 1 | 0 | ||||||||||||
| 127483441 | 12748344 | 12 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 10 MG | 0 | |||||||||||
| 127483441 | 12748344 | 13 | C | GLIFAGE XR | METFORMIN HYDROCHLORIDE | 1 | 500 MG | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127483441 | 12748344 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127483441 | 12748344 | Hypoglycaemia | |
| 127483441 | 12748344 | Injection site infection | |
| 127483441 | 12748344 | Injection site inflammation | |
| 127483441 | 12748344 | Injection site pain | |
| 127483441 | 12748344 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127483441 | 12748344 | 1 | 2006 | 20160830 | 0 | |
| 127483441 | 12748344 | 2 | 2006 | 0 | ||
| 127483441 | 12748344 | 3 | 20160831 | 0 | ||
| 127483441 | 12748344 | 4 | 2006 | 20160830 | 0 | |
| 127483441 | 12748344 | 5 | 2006 | 0 | ||
| 127483441 | 12748344 | 6 | 20160831 | 0 |